SCYX Kapitalisasi Akuntansi SCYNEXIS Inc

International disputes and sanctions are restricting the export of SCYNEXIS, Inc. (SCYX) antimycotics to closed zones, complicating raw material logistics. To reduce costs and avoid disruptions, SCYNEXIS, Inc. (SCYX) has outsourced drug production to external contractors. This chart of stock quotes, which hold a value of 0.07, complements the picture of an eco-friendly approach to drug synthesis and strict adherence to ethical standards during trials.

SCYX Kapitalisasi Buku SCYNEXIS (04.07.2022 - 26.10.2026)

Rincian metrik lan analitis perusahaan Scynexis (SCYX)

- rega lan prakiraan konsensus rega:

Rega bursa SCYNEXIS, Inc.|SCYX - Target konsensus

- data kapitalisasi pasar:

Kapitalisasi pasar SCYNEXIS Inc|SCYX - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Buku Saham SCYNEXIS|SCYX - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku scynexis.com|SCYX - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal SCYNEXIS, Inc.|SCYX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal SCYNEXIS, Inc.|SCYX - Utang perusahaan|Utang marang nilai buku SCYNEXIS Inc

Pambiji fundamental:SCYX - SCYNEXIS

Book capitalization reflects the market value of net assets, measuring the company's actual internal capital minus all liabilities to assess fundamental stability. By analyzing the book capitalization trend of SCYNEXIS, Inc. (SCYX), an investor can see how the transition of SCYNEXIS, Inc. (SCYX) to a royalty-based licensing model minimizes production costs, transforming the balance sheet structure into an efficient lever with high margins and reduced risks.

Analisis pesaing SCYNEXIS, Inc.